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Abstract
Introduction: Polycystic ovary syndrome (PCOS) is the most com-
mon endocrinopathyin women of reproductive age. It causes a me-
tabolic syndrome characterized by insulin resistance, hyperinsulinemia, 
and dyslipidemia. Vitamin d deficiency and its association with PCOS 
still represents a controversial subject in the literature. 
Objective: In this context, this study aimed to understand the asso-
ciation between polycystic ovary syndrome and vitamin d deficiency, 
and how it occurs. 
Method: It was an integrative review conducted in the PubMed, 
Scopus, LILACS, and CINAHL databases from August 2016 to January 
2017, with a sample of 7 articles analyzed in their entirety. 
Results: The evidences according to the studies conducted and the 
conclusions they identified. 
Conclusions: It was concluded that we cannot yet assume that vi-
tamin d deficiency contributes to the pathogenesis of PCOS, nor that 
the syndrome causes vitamin d deficiency, since the studies are contro-
versial and there is a need for research with higher levels of evidence 
to clarify these doubts.
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Introduction
Polycystic ovary syndrome (PCOS) is an endocrinopathy that affects 5 
to 10% of women of reproductive age worldwide, being characteri-
zed by chronic anovulation, hyperandrogenism, and polycystic ovaries 
at ultrasound [1]. Therefore, it is a heterogeneous condition of an-
drogen excess with different degrees of reproductive and metabolic 
dysfunctions [2, 3].
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Furthermore, this syndrome is associated with in-
creased risk of infertility and cardiovascular diseases, 
affecting the quality of life of these women [4]. In 
this context, vitamin D presents an association with 
fertility, since its acting mechanism impacts on both 
reproductive cells and immune system cells [5].
Vitamin d deficiency contributes to the PCOS de-
velopment, thus promoting insulin resistance, which 
increases the risk of cardiovascular disease and 
type 2 diabetes mellitus. On the other hand, other 
authors state that women with PCOS may present 
a higher risk to develop vitamin d deficiency, not 
the opposite [6, 7].
Vitamin d deficiency in women with PCOS is pro-
bably due to the obesity of patients with this patho-
logy. Nevertheless, other studies have shown that 
vitamin d is related to glucose metabolism, through 
insulin regulation, because of changes in insulin re-
ceptor expression and cytokine suppression. Such 
process may be related to insulin resistance during 
vitamin d deficiency, consequently resulting in obe-
sity [3, 4, 5, 6, 7, 8].
In this perspective, there is no consensus in the 
literature regarding the pathophysiology of PCOS 
and vitamin d deficiency, including if there is a real 
distinction in serum vitamin d levels in women with 
and without this disease. Therefore, this study aims 
to understand the association between polycystic 
ovary syndrome and vitamin d deficiency, and how 
it occurs; thus, identifying if there is a difference in 
serum vitamin d levels in women with and without 
PCOS, and whether vitamin d deficiency causes or 
is related to insulin resistance in PCOS patients.
Methods
This is an integrative review study, as it aims to 
synthesize a subject, based on the survey of seve-
ral related studies. The integrative review consists 
of six stages, starting by establishing the hypothesis 
or guiding question, followed by literature search, 
categorization of studies, evaluation of the studies 
included in the review, interpretation of the results, 
and synthesis of the knowledge or presentation of 
the review [9, 10].
In the first stage of the review, the following gui-
ding questions were designed: “Do women diagno-
sed with polycystic ovary syndrome present vitamin 
d deficiency when compared to women without 
this diagnosis?” and “How to establish the causal 
relationship between PCOS and vitamin d deficien-
cy?”
Literature search took place in the National Li-
brary of Medicine and National Institute of Health 
(PubMed), Scopus, Latin American and Caribbean 
Health Sciences Literature (LILACS), and Cumula-
tive Index to Nursing and Allied Health Literature 
(CINAHL) databases. Data collection occurred from 
August 2016 to January 2017, using the controlled 
descriptors “Polycystic Ovary Syndrome” and “Vi-
tamin D”, and the Boolean operator “AND”to com-
bine the descriptors: (“Polycystic Ovary Syndrome”) 
AND “Vitamin D”.
Initial sample comprised 744 articles, of which 77 
were identified in PubMed database, 23 in CINA-
HL, 644 in Scopus, and none in LILACS. Next, the 
following inclusion criteria were applied to refine 
the search: original articles in the English, Portugue-
se, or Spanish languagesthat answered the guiding 
questions of the study and presented a detailed 
methodological description and consistent presen-
tation of the results. Moreover, no filter restriction 
was established for the year of publication of the 
articles.
To identify the articles that best help to unders-
tandthe association between PCOS and serum vita-
min d levels, a previous selection occurred, in which 
only the title of the article was read, followed by 
the abstract and then the full text. The final sample 
consisted of 7 articles: 2 from the PubMed databa-
se, 4 from Scopus, and 1 from CINAHL.
Selected studies were categorized and the neces-
sary information was extracted, which were then 
organized and entered in a table. The articles un-
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Figure 1:  Flowchart for selecting the publications. Brazil, 2016-2017.
Publications identified in databases:
PubMed: 77
Scopus: 644
LILACS:  0
CINAHL: 23
(n=744)
712 publications were excluded: not presenting 
full-text articles; reflective studies; integrative 
reviews;duplicates; and not answering the study 
objective.
8 publications were excluded for not presenting a 
completely described methodology and not focusing 
the association between vitamin d deficiency in 
women with polycystic ovary syndrome.
Id
en
ti
fi
ca
ti
o
n
So
rt
in
g
El
eg
ib
ili
ty
In
cl
u
si
o
n
32 articles remained after refinement in 
the English language
Publications evaluated in their entirety (n=15)
Publications included in the review (n=7)
PubMed (n=2)
CINAHL (n=1)
Scopus (n=4)
derwent a critical evaluation and analysis, followed 
by interpretation of the results, discussion, and re-
commendations. (Figure 1)
Results
Table 1 presents the results of the publications re-
garding the identification, title, objectives, design, 
level of evidence, and the variables of interest of 
the review.
Table 1.  Characterization of the articles according to identification, design, level of evidence, and variables 
of interest of the review.Brazil, 2016-2017.
Title Objectives Design Level of 
Evidence
Sample Results
Diagnostic 
Criteria
Effect of vitamin 
d on clinical and 
biochemical 
parameters 
in polycystic 
ovary syndrome 
women: a meta-
analysis [11]
To investigate the 
association between 
the serum level of 
vitamin d and PCOS, 
and the therapeutic 
effect of vitamin 
d in patients with 
PCOS.
Systematic 
review with 
meta-analysis
I Not available The serum level of vitamin 
d is associated with the 
risk of PCOS, but the 
therapeutic effect of vitamin 
D3 supplementation on 
PCOS remains to be further 
explored.
Rotterdam 
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Title Objectives Design
Level of 
Evidence
Sample Results
Diagnostic 
Criteria
Intrinsic factors rather than 
vitamin d deficiency are related 
to insulin resistance in lean 
women with polycystic ovary 
syndrome [12]
To investigate the correlation 
between insulin resistance and 
serum 25-OH-vit d concentrations 
in lean women with polycystic ovary 
syndrome.
Cross-
sectional
IV 90 women 
(of which 
50 were 
diagnosed 
with PCOS)
An association between 25-OH-Vit d levels and insulin 
resistance is not evident in women with PCOS; insulin 
resistance is related to levels of C-reactive protein, 
luteinizing hormone, and total testosterone in women 
with PCOS.
Rotterdam
Vitamin d deficiency in women 
with polycystic ovary syndrome 
[13]
To investigate the prevalence of 
vitamin d deficiency in Korean 
women with PCOS; and investigate 
the relationship between vitamin 
d status and clinical or metabolic 
features of patients with PCOS.
Cross-
sectional
IV 38 women 
with PCOS 
and 109 
women 
in control 
group
The study found no differences in the absolute level of 
serum vitamin d between PCOS patients and matched 
controls; additionally, it did not find any correlations 
between serum vitamin d level and clinical or metabolic 
profiles between PCOS patients and control group.
Rotterdam
Association of vitamin d 
receptor gene variants with 
polycystic ovary syndrome: A 
case control study [14]
To investigate the possible 
associations between gene variants 
with insulin resistance and serum 
insulin levels.
Case-control III 70 women 
(35 with 
PCOS and 
35 without 
PCOS)
The results showed an association between the 
VDR gene variants and PCOS risk. These data also 
indicated that the INSR “NN” genotype was a marker 
of decreased insulin in women with PCOS. However, 
further studies are needed to confirm the findings and 
elucidate the biological mechanisms by which these 
polymorphisms influence the PCOS risk.
National 
Institute of 
Child Health 
and Human 
Development 
criteria
Comparison of 
25-hydroxyvitamin d and 
calcium levels between 
polycystic ovarian syndrome 
and normal women [15]
To investigate the correlation 
between vitamin d levels and PCOS; 
find a correlation between body 
mass index (BMI), hyperandrogenism 
and metabolic syndrome with serum 
level of 25(OH)D in PCOS patients.
Cross-
sectional
IV 242 women 
(125 with 
PCOS and 
117 healthy 
individuals)
The final result implicates to not only an association 
between vitamin d and metabolic syndrome, but also 
a real peril of pandemic of severe vitamin d deficiency 
which is considered as real threats for women of 
reproductive age. Although a direct association 
between PCOS and vitamin d was not found.
Rotterdam
Association of hypovitaminosis 
d with metabolic disturbances 
in polycystic ovary syndrome 
[16]
To extend the currently rare 
knowledge about the association of 
vitamin d in PCOS women.
Cross-
sectional
IV 206 women 
with PCOS
There was no correlation of 25(OH)D levels with total 
testosterone or free testosterone. Our observations 
did not find any differences among PCOS and healthy 
women with respect to 25(OH)D levels.
Rotterdam
Serum vitamin d levels and 
polycystic ovary syndrome: A 
systematic review and meta-
Analysis [17]
To determine whether serum vitamin 
d levels are lower in PCOS women 
than in non-PCOS women.
Systematic 
review with 
meta-analysis
I Not 
available
Vitamin d deficiency is common among PCOS women; 
there is no evidence that vitamin d deficiency is causally 
linked to the development of PCOS; dysregulation of 
vitamin d metabolism may be a consequence of PCOS.
Not reported 
on the study
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Regarding the year of publication, four articles 
(57.1%) were published in 2015; two (28.5%), in 
2014; and one (14.2%), in 2009. All articles were in 
English. As for the methods, there were four (57.1%) 
with a cross-sectional design, two (28.5%) syste-
matic reviews with meta-analysis, and one (14.2%) 
case-control.
Regarding the level of evidence, 28.5% presented 
level I; 14.2%, level III; and 57.1%, level IV. Level of 
evidence I represents strong evidence, in which at 
least one systematic review of many studies with 
a randomized controlled design can be identified. 
Level of evidence III indicates strong evidence of 
randomized study, time series, matched case-con-
trols, among others. As for the level of evidence 
IV, itshows non-experimental studies that present a 
good delineation and that take place in more than 
one research site [18].
Rotterdam criteria were used as diagnostic re-
ference for the polycystic ovary syndrome in five 
(71.4%) of the studies. As to the research site, two 
studies (28.5%) took place in Iran and one (14.2%) 
in Korea, the other studies did not mention it. Re-
garding the sample size, three studies (42.8%) com-
prised less than 100 patients; and only two (28.5%), 
more than 200. Another important aspect worth 
highlighting is that four studies (57.1%) included 
women with PCOS and control groups (without 
PCOS) for comparison.
Conducted a systematic review with meta-
analysis that showed that vitamin d concentration 
in PCOS patients is lower than in women without 
PCOS, thus suggesting that vitamin d concentration 
was negatively associated with insulin resistance in 
PCOS, but failed to detect the effect of vitamin D3 
supplementation on PCOS [11].
A study of 2014, however, identified that the di-
fference in the 25(OH)D concentration among wo-
men with and without PCOS was not statistically 
significant. In addition, serum vitamin d levels have 
no correlation with insulin resistance. Corroborating 
this research, Kim et al [13] did not verify differences 
between serum vitamin d levels in women with and 
without PCOS; it also found no relationship bet-
ween the 25(OH)D concentration and the hormonal 
and metabolic profile of these patients [12].
Performed a cross-sectional study with 206 wo-
men diagnosed with PCOS and did not identify 
any difference in these patients regarding vitamin 
d concentration, nor in vitamin d levels with total 
testosterone and free testosterone [19].
Conducted a research to investigate, among 
other genes, the association of polymorphisms in 
the vitamin d receptor (VDR) and the risk of deve-
loping polycystic ovary syndrome. They found that 
the gene variants responsible for the VDR may be 
used to indicate susceptibility to PCOS, but further 
studies are needed to determine how these poly-
morphisms influence the PCOS risk [12].
Found that women of reproductive age are at 
high risk for vitamin d deficiency in a global context, 
thus not identifying a direct association between 
PCOS and vitamin d levels [14].
A systematic review to determine whether serum 
vitamin d levels are lower in women with PCOS 
than in women without PCOS and concluded that 
vitamin d deficiency is common among PCOS pa-
tients. Nonetheless, there is no scientific evidence to 
prove that this vitamin deficiency is associated with 
the development of polycystic ovary syndrome, but 
rather that vitamin d deficiency is probably one of 
the consequences of PCOS [17].
Discussion
The prevalence of vitamin d deficiency in women 
with PCOS is still uncertain, and serum 25(OH)D 
levels in women with this syndrome, portrayed in 
some studies, are still inconsistent [20]. This data 
corroborates those found by this research, since the 
existing studies on this subject are still very incon-
clusive.
Studies show the association between vitamin 
d and fertility, so it may be related to the outco-
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me of some pathologies, such as endometriosis 
and polycystic ovary syndrome. Nonetheless, the 
pathophysiology of PCOS usually presents hyperin-
sulinemia and obesity, which represent disorders of 
the endocrine system. Therefore, insulin resistance 
is common in PCOS, not being caused by vitamin 
d deficiency as some of the studies surveyed in the 
review suggest [21].
Unlike these findings, the National Health and 
Nutrition Program identified an association bet-
ween serum 25(OH)D levels and the development 
of the metabolic syndrome. It also states that the 
vitamin d concentration is inversely related to the 
risk of hyperglycemia and insulin resistance [22].
Women with PCOS are more susceptible to severe 
complications, which include insulin resistance, hy-
perinsulinemia, and dyslipidemia. With calcium and 
vitamin d supplementation for eight weeks, PCOS 
patients presented a significant change in insulin 
concentration [3].
Study found that obese women with PCOS had 
lower vitamin d levels than non-obese women with 
PCOS, and that 25(OH)D deficiency was related to 
the development of insulin resistance in these pa-
tients, thus impairing their glucose tolerance [23].
A systematic review concluded that the associa-
tion between vitamin d and metabolic disorders in 
women with PCOS remains obscure. Although the 
literature reports an inverse relationship between 
vitamin d levels and insulin resistance in PCOS pa-
tients, these studies are still very heterogeneous, 
hencehindering a conclusion [24].
On the other hand, other studies already inves-
tigatethe effect of calcium and vitamin d supple-
mentation in women with PCOS, noting that this 
therapy improves the hormonal environment and 
sequelae related to the syndrome. Nevertheless, it 
also suggests the need for further studies to better 
understand these benefits [25].
That the variety of phenotypes of PCOS patients 
and the heterogeneity of available studies make it 
difficult to draw conclusions and suggest the con-
duction of clinical trials with well-defined popula-
tions [26].
Conclusions
It is noticed that, despite the great amount of stu-
dies conducted on t he subject, there is not a single 
conclusion that is shared between authors, quite 
the contrary, some are even contradictory. Therefo-
re, it is concluded that vitamin d levels in PCOS pa-
tients remain a controversial subject, in which some 
authors argue that there is no difference between 
vitamin d levels in women with and without PCOS, 
as well as this vitamin deficiency is not related to 
insulin resistance.
In this context, it is imperative to wait for further 
studies with higher levels of evidence to unders-
tand how the association between polycystic ovary 
syndrome and vitamin d deficiency occurs and to 
clarify doubts in order to provide a more qualified 
and targeted assistance.
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